Lv1
100 积分 2025-01-14 加入
Thyroid dysfunction after immune checkpoint inhibitor treatment in a single-center Chinese cohort: a retrospective study
7天前
已完结
Clinical Characters and Influence Factors of Immune Checkpoint Inhibitor-related Thyroid Dysfunction
10天前
已完结
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial
26天前
已完结
Risk of Death and Adverse Effects in Patients on Liothyronine: A Multisource Systematic Review and Meta-analysis
3个月前
已完结
Clinical Characters and Influence Factors of Immune Checkpoint Inhibitor-related Thyroid Dysfunction
5个月前
已完结
Predictive biomarkers for response to immune checkpoint inhibition
6个月前
已完结
Endocrine immune-related adverse events by immune checkpoint inhibitors and potential predictive markers: a prospective study from a single tertiary center
6个月前
已完结
皖公网安备34019202002308
